Transplantation, AutologousHematopoietic Stem Cell TransplantationBone Marrow TransplantationStem Cell TransplantationTransplantation, HomologousBone MarrowTransplantation ConditioningPeripheral Blood Stem Cell TransplantationMultiple MyelomaBone Marrow CellsAntineoplastic Combined Chemotherapy ProtocolsMelphalanCombined Modality TherapyTreatment OutcomeGraft vs Host DiseaseRemission InductionStem CellsCyclophosphamideSalvage TherapyBone Marrow PurgingDisease-Free SurvivalWhole-Body IrradiationRecurrenceEtoposideLymphoma, Non-HodgkinHodgkin DiseaseHematopoietic Stem CellsLiver TransplantationCytarabineMyeloablative AgonistsCarmustineSurvival RateGraft SurvivalHematologic NeoplasmsHematopoietic Stem Cell MobilizationBusulfanSurvival AnalysisThiotepaVincristineRetrospective StudiesTransplantation ChimeraTissue DonorsKidney TransplantationPrognosisTime FactorsAntigens, CD34Follow-Up StudiesLymphoma, Mantle-CellDoxorubicinBone and BonesAmyloidosisDexamethasoneBoronic AcidsLeukemia, Myeloid, AcuteLeukemiaGranulocyte Colony-Stimulating FactorPyrazinesMesenchymal Stem Cell TransplantationAntineoplastic Agents, AlkylatingHistocompatibility TestingLymphoma, FollicularLymphomaAntibodies, Monoclonal, Murine-DerivedHematopoiesisAntineoplastic AgentsHistocompatibilityCell TransplantationAnemia, AplasticImmunosuppressive AgentsCord Blood Stem Cell TransplantationMyelodysplastic SyndromesAutograftsPrednisoneLymphoma, T-Cell, PeripheralThalidomideNeoplasm, ResidualIfosfamideBone Marrow DiseasesPodophyllotoxinLeukapheresisHeart TransplantationCell DifferentiationInduction ChemotherapyLeukemia, MyeloidTransplantation, IsogeneicGraft RejectionLung TransplantationTransplantation ImmunologyLymphoma, Large B-Cell, DiffusePrecursor Cell Lymphoblastic Leukemia-LymphomaAcute DiseaseBone Marrow ExaminationMaintenance ChemotherapyAntibodies, MonoclonalMice, Inbred C57BLProspective StudiesT-LymphocytesLymphoma, B-CellMitoxantroneFatal Outcome